UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps

Science translational medicine, 2016-10, Vol.8 (361), p.361ra138

2016

Volltextzugriff (PDF)

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

Nature communications, 2017-02, Vol.8 (1), p.14294-14294, Article 14294

2017

Volltextzugriff (PDF)

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer

The Journal of clinical investigation, 2023-08, Vol.133 (16), p.1-16

2023

Volltextzugriff (PDF)

Finding the sweet spot: Targeting RAS in tumors while sparing normal tissue

Cancer cell, 2024-06, Vol.42 (6), p.943-945

2024

Volltextzugriff (PDF)

Combinatorial strategies to target RAS-driven cancers

Nature reviews. Cancer, 2024-05, Vol.24 (5), p.316-337

2024

Volltextzugriff (PDF)

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.23-23, Article 23

2017

Volltextzugriff (PDF)

Bone metastases in lung cancer. Potential novel approaches to therapy

American journal of respiratory and critical care medicine, 2015-10, Vol.192 (7), p.799-809

2015

Volltextzugriff (PDF)

DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11), p.1800-1814

2023

Volltextzugriff (PDF)

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects

American journal of respiratory and critical care medicine, 2018-05, Vol.197 (9), p.1164-1176

2018

Volltextzugriff (PDF)

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

Oncogene, 2016-06, Vol.35 (22), p.2852-2861

2016

Volltextzugriff (PDF)

Abstract B072: Loss of the tumor and metastasis suppressor RasGAP DAB2IP mediates therapeutic resistance in HER2+ breast cancer

Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3_Supplement_1), p.B072-B072

2024

Volltextzugriff (PDF)

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Cancer discovery, 2022-05, Vol.12 (5), p.1356-1377

2022

Volltextzugriff (PDF)

Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

The Journal of pathology, 2016-08, Vol.239 (4), p.438-449

2016

Volltextzugriff (PDF)

Abstract P1-13-06: Loss of emerging tumor and metastasis suppressor RasGAPs mediates therapeutic resistance in HER2+ breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P1-P1-13-06

2023

Volltextzugriff (PDF)

Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma

American journal of respiratory and critical care medicine, 2012-07, Vol.186 (1), p.96-105

2012

Volltextzugriff (PDF)

Abstract P4-08-11: AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-08-11

2023

Volltextzugriff (PDF)

Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis: Matrix-Gla protein in osteosarcoma lung metastases

The Journal of pathology, 2016-08, Vol.239 (4), p.438-449

2016

Volltextzugriff (PDF)

USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities

Cell reports. Medicine, 2023-04, Vol.4 (4), p.101007-101007, Article 101007

2023

Volltextzugriff (PDF)

An integrative cross-tumors approach identifies FOSL1 as an oncogene dependency in KRAS-driven lung cancer

Journal of thoracic oncology, 2016-02, Vol.11 (2), p.S51-S51

2016

Volltextzugriff (PDF)

Blockade of C5aR impairs tumor-induced osteoclastogenesis preventing bone metastasis colonization in lung cancer

Bone Abstracts, 2016-04

2016

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(12)
Animals
(8)
Oncology
(8)
Cell Line, Tumor
(7)
Mice
(5)
Proto-Oncogene Proteins P21 - Genetics
(5)
Proto-Oncogene Proteins P21 - Metabolism
(5)
Cancer
(4)
Cell Biology
(4)
Lung Neoplasms - Metabolism
(4)
Lung Neoplasms - Secondary
(4)
Mutation
(4)
Critical Care Medicine
(3)
Female
(3)
General & Internal Medicine
(3)
Genetic Aspects
(3)
Health Aspects
(3)
Lung Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer

Finding the sweet spot: Targeting RAS in tumors while sparing normal tissue

Combinatorial strategies to target RAS-driven cancers

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

Bone metastases in lung cancer. Potential novel approaches to therapy

DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

Abstract B072: Loss of the tumor and metastasis suppressor RasGAP DAB2IP mediates therapeutic resistance in HER2+ breast cancer

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Tumor ENPP1(CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS - Mutant Colorectal Cancers

Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis

Abstract P1-13-06: Loss of emerging tumor and metastasis suppressor RasGAPs mediates therapeutic resistance in HER2+ breast cancer

Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma

Abstract P4-08-11: AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis: Matrix-Gla protein in osteosarcoma lung metastases

USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities

An integrative cross-tumors approach identifies FOSL1 as an oncogene dependency in KRAS-driven lung cancer

Blockade of C5aR impairs tumor-induced osteoclastogenesis preventing bone metastasis colonization in lung cancer

Suchergebnisse filtern